Cleared Special

K193548 - Mirage Hydrophilic Guidewire, X-pedion Hydrophilic Guidewire (FDA 510(k) Clearance)

Jan 2020
Decision
29d
Days
Class 2
Risk

K193548 is an FDA 510(k) clearance for the Mirage Hydrophilic Guidewire, X-pedion Hydrophilic Guidewire. This device is classified as a Wire, Guide, Catheter (Class II - Special Controls, product code DQX).

Submitted by Micro Therapeutics, Inc. d/b/a ev3 Neurovascular (Irvine, US). The FDA issued a Cleared decision on January 18, 2020, 29 days after receiving the submission on December 20, 2019.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 870.1330.

Submission Details

510(k) Number K193548 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 20, 2019
Decision Date January 18, 2020
Days to Decision 29 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code DQX — Wire, Guide, Catheter
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1330